翻訳と辞書 |
Tetulomab
Tetulomab (HH1) is a murine monoclonal antibody for cancer treatment. It is developed by Erlend Smeland and Steinar Funderud at the Norwegian Radium Hospital.() Tetulomab binds to the glycoprotein CD37 on the surface of mature malignant and non-malignant human B cells and can therefore be used as a tumor-targeting carrier for radioactive and cytotoxic payloads for treatment of hematological cancer.() The Norwegian biotech company (Nordic Nanovector a.s ) has exclusive commercial therapeutic use of Tetulomab and has patented the radioimmunotherapeutic use of Tetulomab against CD37. Tetulomab is the tumor-targeting carrier in the product candidate Betalutin, a radioimmunoconjugate currently being tested in patients with relapsed or refractory low-grade non-Hodgkin’s lymphoma through a Phase I/II (clinical trial ) sponsored by (Nordic Nanovector a.s ). == References ==
() 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Tetulomab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|